We invite postgraduate research proposals in a number of disease areas that impact significantly on patient care. We focus on exploring the mechanisms of disease, understanding the ways disease impacts patients’ lives, utilising new diagnostic and therapeutic techniques and developing new treatments.
As a student you will be registered with a University research institute, for many this is the Institute for Cellular Medicine (ICM). You will be supported in your studies through a structured programme of supervision and training via our Faculty of Medical Sciences Graduate School.
We undertake the following areas of research and offer MPhil, PhD and MD supervision in:
Newcastle hosts one of the most comprehensive organ transplant programmes in the world. This clinical expertise has developed in parallel with the applied immunobiology and transplantation research group. We are investigating aspects of the immunology of autoimmune diseases and cancer therapy, in addition to transplant rejection. We have themes to understand the interplay of the inflammatory and anti-inflammatory responses by a variety of pathways, and how these can be manipulated for therapeutic purposes. Further research theme focusses on primary immunodeficiency diseases.
There is strong emphasis on the integration of clinical investigation with basic science. Our research include:
We also research the effects of UVR on the skin including mitochondrial DNA damage as a UV biomarker.
This area emphasises on translational research, linking clinical- and laboratory-based science. Key research include:
Focus is on applied research and aims to underpin future clinical applications. Technology-oriented and demand-driven research is conducted which relates directly to health priority areas such as:
This research is sustained through extensive internal and external collaborations with leading UK and European academic and industrial groups, and has the ultimate goal of deploying next-generation diagnostic and therapeutic systems in the hospital and health-care environment.
There is a number of research programmes into the genetics, immunology and physiology of kidney disease and kidney transplantation. We maintain close links between basic scientists and clinicians with many translational programmes of work, from the laboratory to first-in-man and phase III clinical trials. Specific areas:
We have particular interests in:
Novel non-invasive methodologies using magnetic resonance are developed and applied to clinical research. Our research falls into two categories:
Our studies cover a broad range of topics (including diabetes, dementia, neuroscience, hepatology, cardiovascular, neuromuscular disease, metabolism, and respiratory research projects), but have a common theme of MR technical development and its application to clinical research.
We focus on connective tissue diseases in three, overlapping research programmes. These programmes aim to understand:
This research theme links with other local, national and international centres of excellence and has close integration of basic and clinical researchers and hosts the only immunotherapy centre in the UK.
Genetic approaches to the individualisation of drug therapy, including anticoagulants and anti-cancer drugs, and in the genetics of diverse non-Mendelian diseases, from diabetes to periodontal disease, are a focus. A wide range of knowledge and experience in both genetics and clinical sciences is utilised, with access to high-throughput genotyping platforms.
Our scientists and clinicians use in situ cellular technologies and large-scale gene expression profiling to study the normal and pathophysiological remodelling of vascular and uteroplacental tissues. Novel approaches to cellular interactions have been developed using a unique human tissue resource. Our research themes include:
We also have preclinical molecular biology projects in breast cancer research.
We conduct a broad range of research activities into acute and chronic lung diseases. As well as scientific studies into disease mechanisms, there is particular interest in translational medicine approaches to lung disease, studying human lung tissue and cells to explore potential for new treatments. Our current areas of research include:
Our research projects are concerned with the harmful effects of chemicals, including prescribed drugs, and finding ways to prevent and minimise these effects. We are attempting to measure the effects of fairly small amounts of chemicals, to provide ways of giving early warning of the start of harmful effects. We also study the adverse side-effects of medicines, including how conditions such as liver disease and heart disease can develop in people taking medicines for completely different medical conditions. Our current interests include: environmental chemicals and organophosphate pesticides, warfarin, psychiatric drugs and anti-cancer drugs.
Our new School of Pharmacy has scientists and clinicians working together on all aspects of pharmaceutical sciences and clinical pharmacy.
This is a multidisciplinary degree that brings together aspects of chemistry, biology and cell biology. The modules are carefully tailored to cover the knowledge in key fields such as:
This degree produces graduates with a critical, analytical and flexible approach to problem solving, enhancing laboratory and professional competence and enabling students to work independently and use their initiative in solving the diverse problems they encounter.
The programme helps you to obtain a creative attitude to the development and manufacture of biotechnology products. The intention is that skills and knowledge can be more readily transferred to professional activities.
The aims of the programme are:
We offer a range of sciences programmes from biotechnology to formulation science. Whatever you choose to study you will be taught by experienced staff in state-of-the-art laboratories and gain the skills you need to succeed in your chosen field. Employability is central to all our programmes and you will benefit from our strong links with employers, industry work placements and professional accreditations.
- Year 1
Students are required to study the following compulsory courses.
Biotechnology Research Projects (60 credits)
Bioinformatics (30 credits)
Research Methods and Data management (30 credits)
English Language Support (for Postgraduate students in the Faculty of Engineering and Science)
Applied Molecular Biology (30 credits)
Students are required to choose 1 course from this list of options.
Biotechnology and Transgenic Crops (30 credits)
Pharmaceutical Biotechnology (30 credits)
Your time at university should be enjoyable and rewarding, and it is important that it is not spoilt by unnecessary financial worries. We recommend that you spend time planning your finances, both before coming to university and while you are here. We can offer advice on living costs and budgeting, as well as on awards, allowances and loans.
Find out more about our fees and the support available to you at our:
- Postgraduate finance pages (https://www.gre.ac.uk/study/finance/postgraduate)
- International students' finance pages (http://www2.gre.ac.uk/students/international/international-students/finance)
Students are assessed through:
This programme involves a series of lectures, seminars and workshops. Case studies will provide you with exposure to up-to-date problems and enhance your problem solving and team-work in a way that simulates an industrial setting. A research project in a well equipped department led by staff with a diversity of research experience will give you the opportunity to carry out novel research and enhance your practical skills, analytical thinking and independence.
Biotechnology and pharmaceutical industries, intellectual property industry (IP), academics, bio-informatics/IT, health services, research and higher degrees (PhD).
Find out how to apply here - https://www2.gre.ac.uk/study/apply